OSAM
TRIB

O'Shaughnessy Asset Management’s Trinity Biotech TRIB Stock Holding History

O'Shaughnessy Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,888
Closed -$989K – 1069
2013
Q4 		$989K Sell
7,888
-17,778
-69% -$2.13M 0.02% 325
2013
Q3 		$2.79M Sell
25,666
-6,148
-19% -$599K 0.07% 192
2013
Q2 		$2.69M Buy
+31,814
New +$2.64M 0.07% 196

Other funds holding TRIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

O'Shaughnessy Asset Management's TRIB Position: Q1 2014 in Review

O'Shaughnessy Asset Management sold out of Trinity Biotech (TRIB) in Q1 2014, closing a stake of 7,888 shares — an estimated $989K sold.

O'Shaughnessy Asset Management first reported a position in TRIB in Q2 2013 and held it in 3 quarters. The position peaked at $2.79M in Q3 2013. 81 funds tracked by Wall St. Rank hold TRIB as of Q1 2014.

  • O'Shaughnessy Asset Management reported no remaining Trinity Biotech position as of Q1 2014 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 7,888 Trinity Biotech shares in Q1 2014, an estimated $989K.
  • O'Shaughnessy Asset Management first reported a position in Trinity Biotech in Q2 2013 and held it in 3 quarters.
  • O'Shaughnessy Asset Management's Trinity Biotech position peaked at $2.79M in Q3 2013.
  • 81 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2014.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2014, filed 15 May 2014.